140 related articles for article (PubMed ID: 3310722)
1. Controlled release morphine tablets: a double-blind trial in patients with advanced cancer.
Hanks GW; Twycross RG; Bliss JM
Anaesthesia; 1987 Aug; 42(8):840-4. PubMed ID: 3310722
[TBL] [Abstract][Full Text] [Related]
2. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.
Goughnour BR; Arkinstall WW; Stewart JH
Cancer; 1989 Jun; 63(11 Suppl):2294-7. PubMed ID: 2720578
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
[TBL] [Abstract][Full Text] [Related]
4. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
Arkinstall WW; Goughnour BR; White JA; Stewart JH
CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release morphine (MST Contin) in advanced cancer. The European experience.
Hanks GW
Cancer; 1989 Jun; 63(11 Suppl):2378-82. PubMed ID: 2655869
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer.
Walsh TD; MacDonald N; Bruera E; Shepard KV; Michaud M; Zanes R
Am J Clin Oncol; 1992 Jun; 15(3):268-72. PubMed ID: 1590284
[TBL] [Abstract][Full Text] [Related]
7. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients.
Portenoy RK; Maldonado M; Fitzmartin R; Kaiko RF; Kanner R
Cancer; 1989 Jun; 63(11 Suppl):2284-8. PubMed ID: 2720577
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
Cundiff D; McCarthy K; Savarese JJ; Kaiko R; Thomas G; Grandy R; Goldenheim P
Cancer; 1989 Jun; 63(11 Suppl):2355-9. PubMed ID: 2720581
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release morphine tablets. A double-blind trial in dental surgery patients.
Hanks GW; Rose NM; Aherne GW; Piall EM; Fairfield S; Trueman T
Br J Anaesth; 1981 Dec; 53(12):1259-64. PubMed ID: 7032558
[TBL] [Abstract][Full Text] [Related]
11. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.
Peat S; Sweet P; Miah Y; Barklamb M; Larsen U
Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain.
Boureau F; Saudubray F; d'Arnoux C; Vedrenne J; Estève M; Roquefeuil B; Siou DK; Brunet R; Ranchère JY; Roussel P
J Pain Symptom Manage; 1992 Oct; 7(7):393-9. PubMed ID: 1484192
[TBL] [Abstract][Full Text] [Related]
13. Cancer pain management with a controlled-release oral morphine preparation.
Lapin J; Houde RW; Kaiko RF; Coyle N; Rogers A; Foley KM
J Pain Symptom Manage; 1989 Sep; 4(3):146-51. PubMed ID: 2778362
[TBL] [Abstract][Full Text] [Related]
14. Clinical observations on controlled-release morphine in cancer pain.
Ventafridda V; Saita L; Barletta L; Sbanotto A; De Conno F
J Pain Symptom Manage; 1989 Sep; 4(3):124-9. PubMed ID: 2778360
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release morphine tablets in patients with chronic cancer pain: a narrative review of controlled clinical trials.
Warfield CA
Cancer; 1998 Jun; 82(12):2299-306. PubMed ID: 9635520
[TBL] [Abstract][Full Text] [Related]
16. Controlled-release morphine in cancer pain. Is a loading dose required when the formulation is changed?
Hoskin PJ; Poulain P; Hanks GW
Anaesthesia; 1989 Nov; 44(11):897-901. PubMed ID: 2480721
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
[TBL] [Abstract][Full Text] [Related]
18. A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin tablets) administered to cancer patients.
Lazarus H; Fitzmartin RD; Goldenheim PD
Hosp J; 1990; 6(4):1-15. PubMed ID: 2088995
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.
Wong JO; Chiu GL; Tsao CJ; Chang CL
Acta Anaesthesiol Sin; 1997 Mar; 35(1):25-32. PubMed ID: 9212478
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of oral morphine for chronic non-cancer pain.
Moulin DE; Iezzi A; Amireh R; Sharpe WK; Boyd D; Merskey H
Lancet; 1996 Jan; 347(8995):143-7. PubMed ID: 8544547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
